InMed Pharmaceuticals Inc.
INM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9,331,077 | $11,076 | $4,680 | $3,419 |
| Short-Term Investments | $42,859 | $0 | $0 | $0 |
| Receivables | $343,469 | $465 | $368 | $263 |
| Inventory | $890,807 | $961 | $814 | $1,103 |
| Other Curr. Assets | $191,755 | $365 | $548 | $685 |
| Total Curr. Assets | $10,799,967 | $12,867 | $6,410 | $5,470 |
| Property Plant & Equip (Net) | $881,549 | $992 | $1,109 | $1,231 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1,579,569 | $1,621 | $1,661 | $1,701 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $100,000 | $100 | $100 | $100 |
| Total NC Assets | $2,561,118 | $2,713 | $2,870 | $3,032 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $13,361,085 | $15,580 | $9,280 | $8,502 |
| Liabilities | – | – | – | – |
| Payables | $515 | $370 | $560 | $575 |
| Short-Term Debt | $592 | $436 | $429 | $420 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,555,663 | $1,034 | $850 | $797 |
| Total Curr. Liab. | $1,554,984 | $1,840 | $1,839 | $1,791 |
| LT Debt | $215,779 | $306 | $419 | $529 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $215,478 | $306 | $419 | $529 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $893 | $741 | $849 | $949 |
| Total Liabilities | $1,770,462 | $2,146 | $2,258 | $2,320 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $91,806,396 | $91,221 | $87,457 | $84,537 |
| Retained Earnings | -$118,964,791 | -$117,238 | -$115,450 | -$113,329 |
| AOCI | $128,569 | $129 | $129 | $129 |
| Other Equity | $38,674,314 | $39,323 | $34,885 | $34,845 |
| Total Equity | $11,590,623 | $13,434 | $7,022 | $6,182 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $13,361,085 | $15,580 | $9,280 | $8,502 |
| Net Debt | -$9,114,706 | -$10,335 | -$3,831 | -$2,470 |